Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q18350013> ?p ?o }
Showing triples 1 to 18 of
18
with 100 triples per page.
- Q18350013 subject Q7214357.
- Q18350013 abstract "Diabetes results from the loss or malfunction of the beta cells in the pancreas that make insulin. Autoimmunity has been the accepted explanation for type 1 diabetes (T1D) for 40 years, but clinical trials of immunotherapy have proved disappointing, and have not provided a means of prevention. The accelerator hypothesis proposes a different explanation for T1D, based on the tempo of beta cell loss and the environmental factors that drive it. The autoimmune diabetes Accelerator Prevention Trial (adAPT) is testing the accelerator hypothesis, by seeking to establish whether a drug which protects the beta cell metformin can slow the tempo of loss sufficiently to reduce the incidence of diabetes in children at risk. The trial is sponsored by the University of Exeter, conducted in Scotland by the Tayside Clinical Trials Unit and funded by JDRF. It will report finally in 2022.".
- Q18350013 wikiPageWikiLink Q103191.
- Q18350013 wikiPageWikiLink Q12206.
- Q18350013 wikiPageWikiLink Q124407.
- Q18350013 wikiPageWikiLink Q1414861.
- Q18350013 wikiPageWikiLink Q1767180.
- Q18350013 wikiPageWikiLink Q192360.
- Q18350013 wikiPageWikiLink Q19484.
- Q18350013 wikiPageWikiLink Q269829.
- Q18350013 wikiPageWikiLink Q3025883.
- Q18350013 wikiPageWikiLink Q419107.
- Q18350013 wikiPageWikiLink Q6107958.
- Q18350013 wikiPageWikiLink Q7214357.
- Q18350013 wikiPageWikiLink Q79460.
- Q18350013 wikiPageWikiLink Q911125.
- Q18350013 comment "Diabetes results from the loss or malfunction of the beta cells in the pancreas that make insulin. Autoimmunity has been the accepted explanation for type 1 diabetes (T1D) for 40 years, but clinical trials of immunotherapy have proved disappointing, and have not provided a means of prevention. The accelerator hypothesis proposes a different explanation for T1D, based on the tempo of beta cell loss and the environmental factors that drive it.".
- Q18350013 label "Accelerator Prevention Trial (adAPT)".